Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mood Effects of Serotonin Agonists: Depression (MESA-D)
NCT07017478Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in major depressive disorder (MDD) comparing Placebo with LSD (26 micrograms) (2 arms). Primary endpoints: Acute Mood Measures at 2 hours, Delayed Mood Measures at 48 hours and 2 more. Started Jun 2025; status: completed.
02
Drugs
Lysergide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07017478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07017478.